Rallis India Ltd, Vinati Organics Ltd, TTK Prestige Ltd, Cyient Ltd are among the other stocks to see a surge in volumes on NSE today, 17 January 2020.

Glaxosmithkline Pharmaceuticals Ltd clocked volume of 6.38 lakh shares by 14:14 IST on NSE, a 14.28 times surge over two-week average daily volume of 44655 shares. The stock lost 0.21% to Rs.1,626.05. Volumes stood at 25104 shares in the last session.

Rallis India Ltd registered volume of 52.32 lakh shares by 14:14 IST on NSE, a 12.62 fold spurt over two-week average daily volume of 4.14 lakh shares. The stock rose 16.42% to Rs.224.80. Volumes stood at 7.74 lakh shares in the last session.

Vinati Organics Ltd recorded volume of 2.29 lakh shares by 14:14 IST on NSE, a 12.07 times surge over two-week average daily volume of 18988 shares. The stock gained 6.72% to Rs.2,135.45. Volumes stood at 11669 shares in the last session.

TTK Prestige Ltd saw volume of 63289 shares by 14:14 IST on NSE, a 8.75 fold spurt over two-week average daily volume of 7233 shares. The stock increased 1.76% to Rs.6,080.00. Volumes stood at 4867 shares in the last session.

Cyient Ltd notched up volume of 7.64 lakh shares by 14:14 IST on NSE, a 6.61 fold spurt over two-week average daily volume of 1.16 lakh shares. The stock rose 0.03% to Rs.451.05. Volumes stood at 2.41 lakh shares in the last session.

Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 February 2020.

Powered by Capital Market - Live News

LIC sold 34.02 lakh shares, or 2.009% stake, in GSK Pharma in the open market on 19 December 2019. The disclosure was made after market hours yesterday, 20 December 2019.

Shares of GSK Pharma fell 0.85% to Rs 1663.90 on Friday.

On the technical front, the stock's RSI (relative strength index) stood at 55.804. The RSI oscillates between zero and 100. Traditionally the RSI is considered overbought when above 70 and oversold when below 30.

The stock was trading above its 50-day moving average (DMA) placed at Rs 1592.12 and 200-day moving average (DMA) placed at Rs 1350.98. Both these levels would serve as support levels in the near term.

On a consolidated basis, GSK Pharma's net profit surged 398.6% to Rs 502.75 crore on 8% increase in net sales to Rs 882.02 crore in Q2 September 2019 over Q2 September 2018.

GSK Pharma is a one of the world's leading research-based pharmaceutical and healthcare companies.

Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals rose 398.61% to Rs 502.75 crore in the quarter ended September 2019 as against Rs 100.83 crore during the previous quarter ended September 2018. Sales rose 8.05% to Rs 882.02 crore in the quarter ended September 2019 as against Rs 816.31 crore during the previous quarter ended September 2018.

Powered by Capital Market - Live News